Imodium Misuse and Abuse May Be Curbed By New Packaging Approved by FDA
The FDA has announced new packaging limits for Imodium and other loperamide-based drugs, to prevent misuse and abuse, which can lead to heart problems.
The FDA has announced new packaging limits for Imodium and other loperamide-based drugs, to prevent misuse and abuse, which can lead to heart problems.
The FDA seeks limits on the number of doses of Imodium available per package due to growing concerns over abuse of the antidiarrheal medication, which can cause severe heart problems…
The FDA is warning that overdosing on Imodium can lead to serious heart problems and even death amid rising reports of abuse.
About 54,000 packaged of Imodium Multi-Symptom Relief have been recalled due to packaging problems, which could reduce the effectiveness of the pills used to control diarrhea.